Cardiology Infectious Disease
IE Mortality Risk Score
Estimates in-hospital mortality risk in infective endocarditis using clinical variables at presentation.
Score interpretation
Low Mortality Risk 0–3
Score 0–3: In-hospital mortality < 10%.
→ Standard IE management. Cardiology and Infectious Disease involvement.
Intermediate Mortality Risk 4–7
Score 4–7: In-hospital mortality 10–30%.
→ Close monitoring. Early cardiothoracic surgery consultation. MDT approach.
High Mortality Risk 8–14
Score ≥ 8: In-hospital mortality > 30%.
→ High-dependency care. Urgent cardiac surgery evaluation. Early goals-of-care discussion.
Interpretation bands for the IE Mortality. Apply clinical judgement and local guidance.
References
- Hasbun R et al. Complications of infective endocarditis. Medicine (Baltimore). 2003;82(6):371-380.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Daptomycin · Cyclic Lipopeptide — MRSA / VRE / Bacteraemia / Endocarditis
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
- Atorvastatin (CKD Cardiovascular Risk) · Cardiovascular Risk in CKD
- Icosapent Ethyl (Omega-3 — Cardiovascular Risk Reduction) · Omega-3 Fatty Acid (Purified EPA — Eicosapentaenoic Acid Ethyl Ester)
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.